Structure

Physi-Chem Properties

Molecular Weight:  610.15
Volume:  552.318
LogP:  -0.17
LogD:  -0.361
LogS:  -2.818
# Rotatable Bonds:  6
TPSA:  269.43
# H-Bond Aceptor:  16
# H-Bond Donor:  10
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.14
Synthetic Accessibility Score:  4.772
Fsp3:  0.444
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.495
MDCK Permeability:  1.6174853953998536e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.864
20% Bioavailability (F20%):  0.043
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.036
Plasma Protein Binding (PPB):  89.66343688964844%
Volume Distribution (VD):  0.695
Pgp-substrate:  15.695527076721191%

ADMET: Metabolism

CYP1A2-inhibitor:  0.057
CYP1A2-substrate:  0.032
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.009
CYP2C9-substrate:  0.102
CYP2D6-inhibitor:  0.023
CYP2D6-substrate:  0.117
CYP3A4-inhibitor:  0.014
CYP3A4-substrate:  0.003

ADMET: Excretion

Clearance (CL):  1.212
Half-life (T1/2):  0.748

ADMET: Toxicity

hERG Blockers:  0.278
Human Hepatotoxicity (H-HT):  0.053
Drug-inuced Liver Injury (DILI):  0.986
AMES Toxicity:  0.833
Rat Oral Acute Toxicity:  0.082
Maximum Recommended Daily Dose:  0.004
Skin Sensitization:  0.931
Carcinogencity:  0.092
Eye Corrosion:  0.003
Eye Irritation:  0.392
Respiratory Toxicity:  0.018

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC65563

Natural Product ID:  NPC65563
Common Name*:   5,6,7,4'-Tetrahydroxyflavonol 3-O-(6-Alpha-L-Rhamnopyransyl-Beta-D-Glucopyranoside)
IUPAC Name:   5,6,7-trihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
Synonyms:  
Standard InCHIKey:  QYRJNVCANQPMCH-QGAVNTNWSA-N
Standard InCHI:  InChI=1S/C27H30O16/c1-8-15(30)20(35)22(37)26(40-8)39-7-13-17(32)21(36)23(38)27(42-13)43-25-19(34)14-12(6-11(29)16(31)18(14)33)41-24(25)9-2-4-10(28)5-3-9/h2-6,8,13,15,17,20-23,26-33,35-38H,7H2,1H3/t8-,13+,15-,17+,20+,21-,22+,23+,26+,27-/m0/s1
SMILES:  Oc1ccc(cc1)c1oc2cc(O)c(c(c2c(=O)c1O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](C)[C@@H]([C@H]([C@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL449793
PubChem CID:   10371537
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003531] Flavonoid-3-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21139 Daphniphyllum calycinum Species Daphniphyllaceae Eukaryota n.a. n.a. n.a. PMID[19099464]
NPO21139 Daphniphyllum calycinum Species Daphniphyllaceae Eukaryota n.a. leaf n.a. PMID[9599286]
NPO21139 Daphniphyllum calycinum Species Daphniphyllaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21139 Daphniphyllum calycinum Species Daphniphyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity IC50 = 43.2 ug.mL-1 PMID[550480]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC65563 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470949
0.9879 High Similarity NPC473682
0.9879 High Similarity NPC241423
0.9879 High Similarity NPC110941
0.9879 High Similarity NPC470444
0.9879 High Similarity NPC126784
0.9879 High Similarity NPC473571
0.9879 High Similarity NPC470443
0.9878 High Similarity NPC8573
0.9878 High Similarity NPC169733
0.9819 High Similarity NPC473073
0.9819 High Similarity NPC473071
0.9816 High Similarity NPC471725
0.9816 High Similarity NPC203259
0.9816 High Similarity NPC134532
0.9816 High Similarity NPC33054
0.9816 High Similarity NPC155877
0.9816 High Similarity NPC176740
0.9816 High Similarity NPC471748
0.976 High Similarity NPC470446
0.976 High Similarity NPC470449
0.976 High Similarity NPC470445
0.976 High Similarity NPC470447
0.976 High Similarity NPC473072
0.9756 High Similarity NPC45522
0.9756 High Similarity NPC169977
0.9756 High Similarity NPC21666
0.9756 High Similarity NPC42773
0.9756 High Similarity NPC24043
0.9756 High Similarity NPC101026
0.9755 High Similarity NPC29958
0.9755 High Similarity NPC67105
0.9755 High Similarity NPC259896
0.9755 High Similarity NPC136042
0.9755 High Similarity NPC67326
0.9755 High Similarity NPC156869
0.9755 High Similarity NPC254855
0.9755 High Similarity NPC255157
0.9755 High Similarity NPC95866
0.9702 High Similarity NPC470455
0.9702 High Similarity NPC148710
0.9702 High Similarity NPC470451
0.9697 High Similarity NPC476472
0.9697 High Similarity NPC294815
0.9697 High Similarity NPC253685
0.9697 High Similarity NPC16194
0.9697 High Similarity NPC473327
0.9697 High Similarity NPC19108
0.9697 High Similarity NPC220173
0.9695 High Similarity NPC3583
0.9695 High Similarity NPC476405
0.9695 High Similarity NPC117260
0.9695 High Similarity NPC26230
0.9695 High Similarity NPC60735
0.9695 High Similarity NPC259152
0.9693 High Similarity NPC227508
0.9639 High Similarity NPC89127
0.9639 High Similarity NPC14187
0.9639 High Similarity NPC472385
0.9639 High Similarity NPC471669
0.9639 High Similarity NPC202908
0.9639 High Similarity NPC292019
0.9639 High Similarity NPC198324
0.9639 High Similarity NPC122467
0.9636 High Similarity NPC204693
0.9634 High Similarity NPC285197
0.9634 High Similarity NPC245014
0.9634 High Similarity NPC282987
0.9634 High Similarity NPC84265
0.9632 High Similarity NPC275454
0.9632 High Similarity NPC52550
0.9632 High Similarity NPC84362
0.9632 High Similarity NPC223424
0.9632 High Similarity NPC317489
0.9632 High Similarity NPC173637
0.9632 High Similarity NPC127546
0.9581 High Similarity NPC168584
0.9581 High Similarity NPC173837
0.9581 High Similarity NPC89052
0.9581 High Similarity NPC251417
0.9578 High Similarity NPC264735
0.9578 High Similarity NPC115760
0.9578 High Similarity NPC294629
0.9578 High Similarity NPC135277
0.9578 High Similarity NPC237435
0.9578 High Similarity NPC43211
0.9578 High Similarity NPC49344
0.9578 High Similarity NPC210094
0.9578 High Similarity NPC101191
0.9578 High Similarity NPC477848
0.9576 High Similarity NPC301683
0.9576 High Similarity NPC190003
0.9576 High Similarity NPC175107
0.9573 High Similarity NPC186807
0.9573 High Similarity NPC219904
0.9573 High Similarity NPC120099
0.9573 High Similarity NPC93337
0.9573 High Similarity NPC226294
0.9573 High Similarity NPC270578
0.9573 High Similarity NPC469931
0.9573 High Similarity NPC45638
0.9573 High Similarity NPC225434
0.9573 High Similarity NPC201292
0.9573 High Similarity NPC105025
0.9573 High Similarity NPC58053
0.9573 High Similarity NPC203050
0.9573 High Similarity NPC52382
0.9573 High Similarity NPC475942
0.9573 High Similarity NPC223747
0.9571 High Similarity NPC308404
0.9571 High Similarity NPC113968
0.9571 High Similarity NPC277174
0.9571 High Similarity NPC73855
0.9571 High Similarity NPC274618
0.9571 High Similarity NPC145038
0.9571 High Similarity NPC88789
0.9571 High Similarity NPC118284
0.9571 High Similarity NPC281131
0.9571 High Similarity NPC135599
0.9571 High Similarity NPC8856
0.9571 High Similarity NPC56077
0.9571 High Similarity NPC115674
0.9571 High Similarity NPC276222
0.9571 High Similarity NPC179950
0.9571 High Similarity NPC210073
0.9571 High Similarity NPC253662
0.9571 High Similarity NPC328940
0.9527 High Similarity NPC36138
0.9524 High Similarity NPC192539
0.9521 High Similarity NPC233994
0.9521 High Similarity NPC211532
0.9521 High Similarity NPC472380
0.9521 High Similarity NPC219043
0.9521 High Similarity NPC472384
0.9521 High Similarity NPC48984
0.9521 High Similarity NPC472382
0.9521 High Similarity NPC473862
0.9521 High Similarity NPC268533
0.9518 High Similarity NPC4390
0.9518 High Similarity NPC236191
0.9518 High Similarity NPC51774
0.9518 High Similarity NPC239549
0.9515 High Similarity NPC21190
0.9515 High Similarity NPC244776
0.9515 High Similarity NPC22195
0.9515 High Similarity NPC116864
0.9515 High Similarity NPC235260
0.9515 High Similarity NPC20505
0.9515 High Similarity NPC155763
0.9515 High Similarity NPC206123
0.9515 High Similarity NPC183357
0.9512 High Similarity NPC265530
0.9512 High Similarity NPC146792
0.9512 High Similarity NPC45618
0.9512 High Similarity NPC226304
0.9512 High Similarity NPC160156
0.9512 High Similarity NPC92565
0.9512 High Similarity NPC325555
0.9512 High Similarity NPC58716
0.9509 High Similarity NPC277205
0.9509 High Similarity NPC55786
0.9509 High Similarity NPC19388
0.9509 High Similarity NPC240431
0.9471 High Similarity NPC470416
0.9464 High Similarity NPC267680
0.9464 High Similarity NPC293626
0.9464 High Similarity NPC253521
0.9464 High Similarity NPC217387
0.9464 High Similarity NPC37668
0.9464 High Similarity NPC196127
0.9464 High Similarity NPC258044
0.9464 High Similarity NPC113836
0.9464 High Similarity NPC35167
0.9461 High Similarity NPC142996
0.9461 High Similarity NPC102028
0.9458 High Similarity NPC211594
0.9458 High Similarity NPC172807
0.9458 High Similarity NPC307518
0.9458 High Similarity NPC267254
0.9458 High Similarity NPC245452
0.9458 High Similarity NPC254540
0.9458 High Similarity NPC153755
0.9458 High Similarity NPC48773
0.9458 High Similarity NPC156977
0.9458 High Similarity NPC205076
0.9455 High Similarity NPC471457
0.9455 High Similarity NPC472381
0.9455 High Similarity NPC86008
0.9455 High Similarity NPC210042
0.9455 High Similarity NPC195257
0.9455 High Similarity NPC95855
0.9455 High Similarity NPC170675
0.9455 High Similarity NPC472383
0.9455 High Similarity NPC209296
0.9455 High Similarity NPC112755
0.9455 High Similarity NPC138927
0.9451 High Similarity NPC99957
0.9451 High Similarity NPC197285
0.9451 High Similarity NPC181616
0.9451 High Similarity NPC21100

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC65563 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9816 High Similarity NPD6797 Phase 2
0.9756 High Similarity NPD7251 Discontinued
0.9578 High Similarity NPD4338 Clinical (unspecified phase)
0.9578 High Similarity NPD7808 Phase 3
0.9515 High Similarity NPD7472 Approved
0.9455 High Similarity NPD7054 Approved
0.9281 High Similarity NPD7074 Phase 3
0.9107 High Similarity NPD7804 Clinical (unspecified phase)
0.9048 High Similarity NPD3818 Discontinued
0.9042 High Similarity NPD6168 Clinical (unspecified phase)
0.9042 High Similarity NPD6167 Clinical (unspecified phase)
0.9042 High Similarity NPD6166 Phase 2
0.8909 High Similarity NPD4381 Clinical (unspecified phase)
0.8841 High Similarity NPD2801 Approved
0.8675 High Similarity NPD3817 Phase 2
0.8667 High Similarity NPD1934 Approved
0.8623 High Similarity NPD3882 Suspended
0.8614 High Similarity NPD2393 Clinical (unspecified phase)
0.8563 High Similarity NPD7993 Clinical (unspecified phase)
0.8563 High Similarity NPD5402 Approved
0.8528 High Similarity NPD1512 Approved
0.8405 Intermediate Similarity NPD1511 Approved
0.8402 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD7075 Discontinued
0.8323 Intermediate Similarity NPD4380 Phase 2
0.8297 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8256 Intermediate Similarity NPD5494 Approved
0.8225 Intermediate Similarity NPD6801 Discontinued
0.8202 Intermediate Similarity NPD6559 Discontinued
0.8182 Intermediate Similarity NPD3751 Discontinued
0.8176 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD3787 Discontinued
0.8144 Intermediate Similarity NPD5403 Approved
0.8133 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD1653 Approved
0.8072 Intermediate Similarity NPD6799 Approved
0.8024 Intermediate Similarity NPD5401 Approved
0.7933 Intermediate Similarity NPD5844 Phase 1
0.7927 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7912 Intermediate Similarity NPD8312 Approved
0.7912 Intermediate Similarity NPD8313 Approved
0.7898 Intermediate Similarity NPD6959 Discontinued
0.7895 Intermediate Similarity NPD6777 Approved
0.7895 Intermediate Similarity NPD6776 Approved
0.7895 Intermediate Similarity NPD6779 Approved
0.7895 Intermediate Similarity NPD6782 Approved
0.7895 Intermediate Similarity NPD6781 Approved
0.7895 Intermediate Similarity NPD6778 Approved
0.7895 Intermediate Similarity NPD6780 Approved
0.7879 Intermediate Similarity NPD1549 Phase 2
0.7877 Intermediate Similarity NPD7228 Approved
0.7865 Intermediate Similarity NPD7435 Discontinued
0.7861 Intermediate Similarity NPD1465 Phase 2
0.7816 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7802 Intermediate Similarity NPD7685 Pre-registration
0.7797 Intermediate Similarity NPD1247 Approved
0.7796 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD6599 Discontinued
0.7772 Intermediate Similarity NPD7698 Approved
0.7772 Intermediate Similarity NPD7696 Phase 3
0.7772 Intermediate Similarity NPD7697 Approved
0.7759 Intermediate Similarity NPD7819 Suspended
0.7758 Intermediate Similarity NPD2796 Approved
0.7753 Intermediate Similarity NPD6232 Discontinued
0.7746 Intermediate Similarity NPD7411 Suspended
0.7738 Intermediate Similarity NPD6190 Approved
0.773 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD7473 Discontinued
0.7709 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7704 Intermediate Similarity NPD7701 Phase 2
0.7697 Intermediate Similarity NPD1510 Phase 2
0.7665 Intermediate Similarity NPD8151 Discontinued
0.7641 Intermediate Similarity NPD7870 Phase 2
0.7641 Intermediate Similarity NPD7871 Phase 2
0.7632 Intermediate Similarity NPD6534 Approved
0.7632 Intermediate Similarity NPD6535 Approved
0.7626 Intermediate Similarity NPD7874 Approved
0.7626 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD7266 Discontinued
0.7604 Intermediate Similarity NPD7699 Phase 2
0.7604 Intermediate Similarity NPD7700 Phase 2
0.7598 Intermediate Similarity NPD7199 Phase 2
0.7588 Intermediate Similarity NPD7783 Phase 2
0.7588 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD6234 Discontinued
0.7584 Intermediate Similarity NPD919 Approved
0.7574 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1613 Approved
0.7557 Intermediate Similarity NPD8455 Phase 2
0.7514 Intermediate Similarity NPD7240 Approved
0.7514 Intermediate Similarity NPD3926 Phase 2
0.75 Intermediate Similarity NPD7801 Approved
0.75 Intermediate Similarity NPD37 Approved
0.7475 Intermediate Similarity NPD7584 Approved
0.7472 Intermediate Similarity NPD4965 Approved
0.7472 Intermediate Similarity NPD4967 Phase 2
0.7472 Intermediate Similarity NPD4966 Approved
0.7456 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD943 Approved
0.7455 Intermediate Similarity NPD1240 Approved
0.7449 Intermediate Similarity NPD6823 Phase 2
0.741 Intermediate Similarity NPD230 Phase 1
0.7374 Intermediate Similarity NPD8320 Phase 1
0.7374 Intermediate Similarity NPD8319 Approved
0.7371 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD3750 Approved
0.7365 Intermediate Similarity NPD1607 Approved
0.7341 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD2935 Discontinued
0.7333 Intermediate Similarity NPD3749 Approved
0.7317 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7316 Intermediate Similarity NPD8434 Phase 2
0.7316 Intermediate Similarity NPD8150 Discontinued
0.7305 Intermediate Similarity NPD1933 Approved
0.7278 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7768 Phase 2
0.7273 Intermediate Similarity NPD3027 Phase 3
0.7267 Intermediate Similarity NPD4628 Phase 3
0.726 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD1551 Phase 2
0.7229 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD6212 Phase 3
0.7216 Intermediate Similarity NPD6213 Phase 3
0.7207 Intermediate Similarity NPD6844 Discontinued
0.7202 Intermediate Similarity NPD447 Suspended
0.72 Intermediate Similarity NPD2532 Approved
0.72 Intermediate Similarity NPD2534 Approved
0.72 Intermediate Similarity NPD2533 Approved
0.7186 Intermediate Similarity NPD6233 Phase 2
0.7121 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD920 Approved
0.711 Intermediate Similarity NPD2800 Approved
0.711 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD7585 Approved
0.709 Intermediate Similarity NPD5953 Discontinued
0.7085 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD3748 Approved
0.7065 Intermediate Similarity NPD7680 Approved
0.7044 Intermediate Similarity NPD7583 Approved
0.7039 Intermediate Similarity NPD3226 Approved
0.7039 Intermediate Similarity NPD7458 Discontinued
0.7024 Intermediate Similarity NPD6798 Discontinued
0.7016 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD4360 Phase 2
0.7005 Intermediate Similarity NPD4363 Phase 3
0.6994 Remote Similarity NPD1091 Approved
0.6984 Remote Similarity NPD7286 Phase 2
0.6977 Remote Similarity NPD7033 Discontinued
0.6949 Remote Similarity NPD7390 Discontinued
0.6946 Remote Similarity NPD9494 Approved
0.6936 Remote Similarity NPD6099 Approved
0.6936 Remote Similarity NPD6100 Approved
0.6923 Remote Similarity NPD2313 Discontinued
0.6914 Remote Similarity NPD6674 Discontinued
0.6914 Remote Similarity NPD1652 Phase 2
0.6914 Remote Similarity NPD1243 Approved
0.6905 Remote Similarity NPD6832 Phase 2
0.6905 Remote Similarity NPD4908 Phase 1
0.6901 Remote Similarity NPD6355 Discontinued
0.6897 Remote Similarity NPD2344 Approved
0.6897 Remote Similarity NPD2346 Discontinued
0.6893 Remote Similarity NPD643 Clinical (unspecified phase)
0.6886 Remote Similarity NPD2798 Approved
0.6879 Remote Similarity NPD2799 Discontinued
0.686 Remote Similarity NPD6651 Approved
0.6852 Remote Similarity NPD8059 Phase 3
0.6852 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6848 Remote Similarity NPD5353 Approved
0.6839 Remote Similarity NPD7549 Discontinued
0.6826 Remote Similarity NPD1203 Approved
0.6825 Remote Similarity NPD2403 Approved
0.6824 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6816 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6809 Remote Similarity NPD5711 Approved
0.6809 Remote Similarity NPD5710 Approved
0.6807 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6802 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6802 Remote Similarity NPD5124 Phase 1
0.6802 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6788 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6782 Remote Similarity NPD1509 Clinical (unspecified phase)
0.678 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6776 Remote Similarity NPD7907 Approved
0.6776 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6772 Remote Similarity NPD5242 Approved
0.6765 Remote Similarity NPD5005 Approved
0.6765 Remote Similarity NPD5006 Approved
0.6758 Remote Similarity NPD5808 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data